CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 28, 2013	Sep. 29, 2012
Cash flows from operating activities:
Consolidated net income	$ 264,957	$ 331,896
Adjustments to reconcile consolidated net income to net cash provided by operations:
Depreciation and amortization	96,540	84,904
Amortization of stock-based compensation	24,247	24,861
Equity in earnings of affiliated companies	(5,227)	(5,766)
Deferred income taxes	15,311	17,966
Restructuring, integration, and other charges	52,260	24,419
Excess tax benefits from stock-based compensation arrangements	(6,937)	(5,083)
Loss on prepayment of debt	2,627	0
Other	182	(4,340)
Change in assets and liabilities, net of effects of acquired businesses:
Accounts receivable	386,542	235,512
Inventories	(94,180)	(99,523)
Accounts payable	(361,349)	31,915
Accrued expenses	(204,013)	(107,194)
Other assets and liabilities	64,685	(42,284)
Net cash provided by operating activities	235,645	487,283
Cash flows from investing activities:
Cash consideration paid for acquired businesses	(43,392)	(191,250)
Acquisition of property, plant, and equipment	(85,465)	(75,574)
Purchase of cost method investments	(3,000)	(15,000)
Net cash used for investing activities	(131,857)	(281,824)
Cash flows from financing activities:
Change in short-term and other borrowings	(22,282)	7,795
Repayment of long-term bank borrowings, net	(242,900)	(25,000)
Net proceeds from note offering	591,156	0
Redemption of senior notes	(338,184)	0
Proceeds from exercise of stock options	30,368	11,481
Excess tax benefits from stock-based compensation arrangements	6,937	5,083
Repurchases of common stock	(312,613)	(222,795)
Net cash used for financing activities	(287,518)	(223,436)
Effect of exchange rate changes on cash	25,836	(20,360)
Net decrease in cash and cash equivalents	(157,894)	(38,337)
Cash and cash equivalents at beginning of period	409,684	396,887
Cash and cash equivalents at end of period	$ 251,790	$ 358,550